These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 27694442)
21. Roles of E2F1 in mesangial cell proliferation in vitro. Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784 [TBL] [Abstract][Full Text] [Related]
22. Chromatin remodeling gene ARID2 targets cyclin D1 and cyclin E1 to suppress hepatoma cell progression. Duan Y; Tian L; Gao Q; Liang L; Zhang W; Yang Y; Zheng Y; Pan E; Li S; Tang N Oncotarget; 2016 Jul; 7(29):45863-45875. PubMed ID: 27351279 [TBL] [Abstract][Full Text] [Related]
23. AKAP95 regulates ubiquitination and degradation of cyclin Ds/Es, influencing the G1/S transition of lung cancer cells. Deng Z; Dou L; Luo Z; Liu R; Zhang J; Wang J; Wang D; Guo D; An R; Yao Y; Qiu G; Zhang Y Mol Carcinog; 2024 Oct; 63(10):1907-1921. PubMed ID: 38923703 [TBL] [Abstract][Full Text] [Related]
24. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest. Mann DJ; Jones NC Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352 [TBL] [Abstract][Full Text] [Related]
25. Construction of a cyclin D1-Cdk2 fusion protein to model the biological functions of cyclin D1-Cdk2 complexes. Chytil A; Waltner-Law M; West R; Friedman D; Aakre M; Barker D; Law B J Biol Chem; 2004 Nov; 279(46):47688-98. PubMed ID: 15355984 [TBL] [Abstract][Full Text] [Related]
26. Three-dimensional collagen represses cyclin E1 via β1 integrin in invasive breast cancer cells. Wu Y; Guo X; Brandt Y; Hathaway HJ; Hartley RS Breast Cancer Res Treat; 2011 Jun; 127(2):397-406. PubMed ID: 20607601 [TBL] [Abstract][Full Text] [Related]
27. Regulation of cyclin E1 expression in human pluripotent stem cells and derived neural progeny. Rodríguez Varela MS; Mucci S; Videla Richardson GA; Morris Hanon O; Furmento VA; Miriuka SG; Sevlever GE; Scassa ME; Romorini L Cell Cycle; 2018; 17(14):1721-1744. PubMed ID: 29995582 [TBL] [Abstract][Full Text] [Related]
28. CCAAT/enhancer-binding protein beta inhibits proliferation in monocytic cells by affecting the retinoblastoma protein/E2F/cyclin E pathway but is not directly required for macrophage morphology. Gutsch R; Kandemir JD; Pietsch D; Cappello C; Meyer J; Simanowski K; Huber R; Brand K J Biol Chem; 2011 Jul; 286(26):22716-29. PubMed ID: 21558273 [TBL] [Abstract][Full Text] [Related]
29. S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation. Leng X; Connell-Crowley L; Goodrich D; Harper JW Curr Biol; 1997 Sep; 7(9):709-12. PubMed ID: 9285720 [TBL] [Abstract][Full Text] [Related]
30. Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells. Bindels EM; Lallemand F; Balkenende A; Verwoerd D; Michalides R Oncogene; 2002 Nov; 21(53):8158-65. PubMed ID: 12444551 [TBL] [Abstract][Full Text] [Related]
32. Regulation of the G1/S transition phase in mesangial cells by E2F1. Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F Kidney Int; 1999 Oct; 56(4):1238-41. PubMed ID: 10504464 [TBL] [Abstract][Full Text] [Related]
33. Location, location, location: the role of cyclin D1 nuclear localization in cancer. Gladden AB; Diehl JA J Cell Biochem; 2005 Dec; 96(5):906-13. PubMed ID: 16163738 [TBL] [Abstract][Full Text] [Related]
34. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions. Oswald F; Lovec H; Möröy T; Lipp M Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548 [TBL] [Abstract][Full Text] [Related]
35. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators. Morris L; Allen KE; La Thangue NB Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242 [TBL] [Abstract][Full Text] [Related]
36. Regulation of the cyclin E gene by transcription factor E2F1. Ohtani K; DeGregori J; Nevins JR Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12146-50. PubMed ID: 8618861 [TBL] [Abstract][Full Text] [Related]
37. Overexpression of cyclin D1 contributes to malignancy by up-regulation of fibroblast growth factor receptor 1 via the pRB/E2F pathway. Tashiro E; Maruki H; Minato Y; Doki Y; Weinstein IB; Imoto M Cancer Res; 2003 Jan; 63(2):424-31. PubMed ID: 12543798 [TBL] [Abstract][Full Text] [Related]
38. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis. Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi DF; Asara G; Casabona D; Frau M; Seddaiu MA; Feo F Hepatology; 2002 Jun; 35(6):1341-50. PubMed ID: 12029619 [TBL] [Abstract][Full Text] [Related]
39. Differential regulation of cell cycle machinery by various antiproliferative agents is linked to macrophage arrest at distinct G1 checkpoints. Vadiveloo PK; Vairo G; Novak U; Royston AK; Whitty G; Filonzi EL; Cragoe EJ; Hamilton JA Oncogene; 1996 Aug; 13(3):599-608. PubMed ID: 8760301 [TBL] [Abstract][Full Text] [Related]
40. SALL2 represses cyclins D1 and E1 expression and restrains G1/S cell cycle transition and cancer-related phenotypes. E Hermosilla V; Salgado G; Riffo E; Escobar D; Hepp MI; Farkas C; Galindo M; Morín V; García-Robles MA; Castro AF; Pincheira R Mol Oncol; 2018 Jun; 12(7):1026-1046. PubMed ID: 29689621 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]